Capital Advantage, Inc. Pfizer Inc Transaction History
Capital Advantage, Inc.
- $547 Million
- Q1 2025
A detailed history of Capital Advantage, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Capital Advantage, Inc. holds 14,896 shares of PFE stock, worth $360,334. This represents 0.07% of its overall portfolio holdings.
Number of Shares
14,896
Previous 14,896
-0.0%
Holding current value
$360,334
Previous $395,000
4.56%
% of portfolio
0.07%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding PFE
# of Institutions
3,371Shares Held
3.61BCall Options Held
102MPut Options Held
130M-
Vanguard Group Inc Valley Forge, PA523MShares$12.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$7.18 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$3.04 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.5 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $136B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...